This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chung, A. S. Articles by Chin, Y. E. Search for Related Content PubMed PubMed Citation Articles by Chung, A. S. Articles by Chin, Y. E.

Ankyrin Repeat and SOCS Box 3 (ASB3) Mediates Ubiquitination and Degradation of Tumor Necrosis Factor Receptor II

Department of Molecular and Cell Biology and Biochemistry,¹ Department of Surgery, Brown University School of Medicine and Rhode Island Hospital, Providence, Rhode Island 02903²

Received 15 December 2004/ Returned for modification 14 January 2005/ Accepted 14 February 2005

Ankyrin repeat and SOCS box (ASB) family members have a C-terminal SOCS box and an N-terminal ankyrin-related sequence of variable repeats belonging to the SOCS superfamily. While SH2-domain-bearing SOCS proteins are mainly involved in the negative feedback regulation of the protein tyrosine kinase-STAT pathway in response to a variety of cytokines, the roles of ASB family members remain largely unknown. To investigate ASB functions, we screened for ASB3-interacting factors by using antibody array technology and identified tumor necrosis factor receptor II (TNF-R2) as an ASB3 binding target. ASB3 expression and activities are required for (i) TNF-R2 ubiquitination both in vivo and in vitro, (ii) TNF-R2 proteolysis via the proteasome pathway, and (iii) the inhibition of TNF-R2-mediated Jun N-terminal protein kinase (JNK) activation. While the ankyrin repeats of ASB3 interact with the C-terminal 37 amino acids of TNF-R2, the SOCS box of ASB3 is responsible for recruiting the E3 ubiquitin ligase adaptors Elongins-B/C, leading to TNF-R2 ubiquitination on multiple lysine residues within its C-terminal region. Downregulation of ASB3 expression by a small interfering RNA inhibited TNF-R2 degradation and potentiated TNF-R2-mediated cytotoxicity. The data presented here implicate ASB3 as a negative regulator of TNF-R2-mediated cellular responses to TNF- by direct targeting of TNF-R2 for ubiquitination and proteasome-mediated degradation.

This article has been cited by other articles:

• Liu, X.-L., Yuan, J.-Y., Zhang, J.-W., Zhang, X.-H., Wang, R.-X. (2007). Differential gene expression in human hematopoietic stem cells specified toward erythroid, megakaryocytic, and granulocytic lineage. J. Leukoc. Biol. 82: 986-1002 [Abstract] [Full Text]  
• Ferguson, J. E. III, Wu, Y., Smith, K., Charles, P., Powers, K., Wang, H., Patterson, C. (2007). ASB4 Is a Hydroxylation Substrate of FIH and Promotes Vascular Differentiation via an Oxygen-Dependent Mechanism. Mol. Cell. Biol. 27: 6407-6419 [Abstract] [Full Text]  
• Debrincat, M. A., Zhang, J.-G., Willson, T. A., Silke, J., Connolly, L. M., Simpson, R. J., Alexander, W. S., Nicola, N. A., Kile, B. T., Hilton, D. J. (2007). Ankyrin Repeat and Suppressors of Cytokine Signaling Box Protein Asb-9 Targets Creatine Kinase B for Degradation. J. Biol. Chem. 282: 4728-4737 [Abstract] [Full Text]  
• Diks, S. H., Bink, R. J., van de Water, S., Joore, J., van Rooijen, C., Verbeek, F. J., den Hertog, J., Peppelenbosch, M. P., Zivkovic, D. (2006). The novel gene asb11: a regulator of the size of the neural progenitor compartment. J. Cell Biol. 174: 581-592 [Abstract] [Full Text]  
• Achanta, G., Modzelewska, A., Feng, L., Khan, S. R., Huang, P. (2006). A Boronic-Chalcone Derivative Exhibits Potent Anticancer Activity through Inhibition of the Proteasome. Mol. Pharmacol. 70: 426-433 [Abstract] [Full Text]  
• Reecy, J. M., Spurlock, D. M., Stahl, C. H. (2006). Gene expression profiling: Insights into skeletal muscle growth and development. J ANIM SCI 84: E150-E [Abstract] [Full Text]